Plastic Surgery MSO: How Management Services Deals Really Work

Plastic Surgery MSO: How Management Services Deals Really Work

A plastic surgery MSO is how most private equity money reaches a surgeon’s practice, even though most surgeons have never read a management services agreement before one lands on their desk. The structure exists for legal reasons, it shapes how you’re paid and what you control after a sale, and in 2026 it’s getting more attention from state regulators than ever.

This guide explains what an MSO is, why it’s used, how an MSO deal differs from a full sale, the terms that matter most, the new state rules and the questions to ask before you sign. It supports our main guide to who buys plastic surgery practices.

Key takeaways

  • An MSO provides non-clinical services to a physician-owned practice. In most PE deals, the MSO buys the practice’s non-clinical assets while a physician entity keeps clinical control.
  • The structure exists because of state corporate practice of medicine rules, which limit who can own a practice or direct clinical care (DLA Piper).
  • The management services agreement and management fee decide how much profit flows to the MSO and how much control you keep.
  • California’s SB 351, effective January 1, 2026, restricts what private equity-backed managers can control in physician practices (Sidley Austin).

What is a plastic surgery MSO?

A plastic surgery MSO is a management services organization that provides a practice’s non-clinical functions, such as marketing, billing, staffing support, technology, purchasing and finance, under a long-term contract. In a private equity deal, the MSO is usually the company the investor owns, and it’s paid a management fee by the physician-owned practice.

Some MSOs are owned by physicians themselves. Physician Growth Partners, for example, lists Cosmetic Physician Partners as a physician-owned MSO without a traditional private equity sponsor. But most MSOs surgeons encounter today are backed by private equity and serve as the platform through which a sponsor acquires practices.

Why do plastic surgery deals use an MSO?

Because many states don’t allow non-physicians to own a medical practice or control clinical decisions. The MSO structure lets an investor own the business side while a licensed physician owns the professional entity and directs patient care. It’s a legal workaround, and how well it’s built determines whether it holds up.

DLA Piper describes the model plainly: a licensed professional owns the professional entity and controls clinical services, including patient care, treatment plans and the employment of clinical staff, while the MSO provides administrative support through a management services agreement. The rules vary by state and come from a patchwork of statutes, case law, attorney general opinions and licensing board guidance.

How does an MSO deal work?

The MSO buys your practice’s non-clinical assets and goodwill for cash and often equity. Your professional entity stays physician-owned and signs a long-term management services agreement with the MSO. You sign an employment agreement with the professional entity, and the MSO’s management fee captures most of the practice’s profit.

A typical structure has four pieces:

  1. Asset purchase. The MSO buys equipment, leases, contracts, trade names and non-clinical goodwill.
  2. Management services agreement. The MSO provides services to the professional entity for a fee, often for decades.
  3. Physician ownership. A licensed physician, sometimes one designated by the MSO, owns the professional entity.
  4. Employment agreement. You and other surgeons are employed by the professional entity with defined compensation.

Many structures also include agreements that let the MSO replace the physician owner of the professional entity under certain conditions. That’s a point regulators are now examining closely.

What is the difference between an MSO deal and a full sale?

In a full sale, a buyer acquires the entire practice, including its clinical operations, which is only possible where the buyer is allowed to own a medical practice, such as another surgeon or a physician-owned group. In an MSO deal, the investor buys the non-clinical business and manages it, while clinical ownership stays with a physician entity.

FeatureFull saleMSO deal
Who owns the clinical practice afterThe buyer (usually physicians)A physician-owned entity
What’s soldThe whole practiceNon-clinical assets and goodwill
How profit flowsTo the new ownerMostly to the MSO through the management fee
Typical buyerSurgeon or physician groupPE-backed platform
Equity for youRareOften rollover equity in the MSO
Regulatory focusStandard licensingCorporate practice rules, fee and control terms

For you, the practical differences are control and pay. In an MSO deal, you’re usually an employee of a physician entity whose economics are set by the management agreement, and your upside often comes through rollover equity in the MSO.

How does a plastic surgery MSO make money?

Through the management fee it collects from affiliated practices, through savings from shared purchasing, marketing and administration, and ultimately through selling the MSO at a higher value than its investors paid. Adding practices at lower multiples and selling the larger group at a higher one is central to the model.

That last point matters to you if you take rollover equity. Your stake grows if the MSO adds practices well, keeps its surgeons and grows earnings. It shrinks if the MSO overpays, loses surgeons or takes on too much debt. Our guide to plastic surgery practice EBITDA multiples explains how that gap between buying and selling multiples works.

What should a management services agreement include?

The scope of services, the management fee and how it’s calculated, the term and renewal, termination rights, decision-making authority, how clinical independence is protected, and what happens if the agreement ends. It’s the most important document in an MSO deal after the purchase agreement, and it deserves your own attorney’s close review.

Terms to look at carefully:

  • Fee structure. A fixed fee, cost plus a markup, or a percentage of revenue or profit. The fee decides how much stays in the professional entity.
  • Clinical carve-outs. Written protection for your decisions on procedures, patient selection, clinical staffing and medical records.
  • Marketing control. Who approves advertising, pricing and before-and-after content, and who’s accountable for claims.
  • Term and exit. How long the agreement runs and whether it can be ended for poor performance.
  • Physician owner succession. Who can replace the owner of the professional entity, and under what conditions.

How are state rules changing plastic surgery MSO deals in 2026?

States are tightening oversight of how much control MSOs and their investors hold. California’s SB 351, effective January 1, 2026, bars private equity and hedge fund managers from controlling clinical decisions and key business functions, and voids certain non-compete and non-disparagement clauses. Enforcement actions and new laws elsewhere point the same way.

Sidley Austin notes SB 351 prohibits interference with clinical decisions and bars control over medical records, staffing decisions, payer relationships, billing decisions and equipment selection, with attorney general enforcement. It voids clauses that stop physicians competing after separation or speaking publicly about quality of care, though it permits non-competes tied to the sale of a business.

Enforcement is active. DLA Piper reports a $4.5 million California settlement with Carbon Health in June 2026 over MSO control of functions including advertising and payer negotiations, a $2 million Aspen Dental settlement in May 2026, a California attorney general brief arguing that MSO rights to replace physician owners violate the doctrine, and Vermont’s Act 133, effective July 1, 2026. Oregon has one of the most restrictive laws in the country.

Is a plastic surgery MSO deal right for you?

It can be, if you want a strong price, capital, operational support and a share of future growth through rollover equity, and you’re comfortable working within a management agreement. It may not suit you if independence over marketing, staffing and pricing matters most. Compare MSO offers with surgeon buyers and internal succession.

Surgeons who do well in MSO deals usually negotiate three things carefully: a fair management fee that leaves the practice healthy, clear written clinical independence, and rollover equity they understand. Our guide to private equity plastic surgery practices covers the investor side, and our guide to plastic surgery rollover equity explains how to value the equity portion.

Questions to ask before selling a practice to an MSO

Ask who owns the MSO and its fund timeline, how the management fee is calculated, who will own your professional entity and who can replace them, what clinical decisions stay with you, how marketing is approved, what happens if you leave, and how the structure complies with your state’s rules. Then talk to surgeons already in the MSO.

A few more worth asking:

  • How has the management fee changed for other practices after joining?
  • How much debt does the MSO carry, and how does it affect my rollover equity?
  • What does the MSO centralize, and what stays local?
  • How are disputes between the MSO and physicians resolved?
  • Has the MSO faced any regulatory inquiries or lawsuits?

What happens to your employment after an MSO deal?

You typically become an employee of the physician-owned professional entity, not the MSO, under an employment agreement with defined compensation, a term of several years and a non-compete. Your pay formula and clinical independence are set in that agreement, so negotiate it alongside the purchase terms.

TUSK Practice Sales says employment agreements in plastic surgery deals typically run three to five years (PR Newswire). Our guide to the post-close employment agreement for surgeons covers compensation, autonomy and non-competes in detail.

Frequently asked questions

What does MSO stand for in plastic surgery?

MSO stands for management services organization. It provides non-clinical services, such as marketing, billing, technology, staffing support and finance, to a physician-owned plastic surgery practice under a long-term management services agreement. In private equity deals, the MSO is usually the company the investor owns.

Why can’t private equity buy a plastic surgery practice directly?

In many states, corporate practice of medicine rules bar non-physicians from owning a medical practice or controlling clinical decisions. The MSO structure lets investors own the business side while a licensed physician owns the professional entity. The rules vary by state, and some, like California and Oregon, are particularly strict.

What is a management fee in an MSO deal?

It’s what the professional entity pays the MSO for its services. It may be a fixed amount, cost plus a markup, or a percentage of revenue or profit. The fee determines how much of the practice’s profit flows to the MSO and its investors, so its structure is one of the most important terms to negotiate.

Do I keep control of clinical decisions in an MSO deal?

You should, and the agreements should say so explicitly. State laws require clinical decisions to stay with licensed physicians, and California’s SB 351 bars private equity-backed managers from interfering with them. Make sure procedures, patient selection, clinical staffing and medical records remain under physician control in writing.

Is selling to an MSO the same as selling my practice?

Not exactly. In an MSO deal, you usually sell the non-clinical assets and goodwill, while clinical ownership stays with a physician entity that contracts with the MSO. The economic result can resemble a sale, with cash and often rollover equity, but you typically continue as an employee under the new structure.

How are new state laws affecting plastic surgery MSOs?

States are scrutinizing how much control MSOs hold. California’s SB 351 took effect January 1, 2026, Vermont’s Act 133 took effect July 1, 2026, and California’s attorney general has reached corporate practice settlements. Buyers are structuring agreements more carefully, and sellers should confirm compliance with their own state’s rules.

Plastic surgery MSO: the bottom line

A plastic surgery MSO can bring capital, support and a second payday, but its value to you depends on the management fee, your clinical independence and the equity you receive. Read the management services agreement as closely as the purchase price, confirm your state’s rules and talk to surgeons already inside.

Weighing an MSO offer? Get the Plastic Surgery Exit Report newsletter for quarterly buyer updates, or book a confidential conversation with the plastic surgery team at Olympic M&A before you sign. Disclosure: Plastic Surgery Exit Report is published in partnership with Olympic M&A, a healthcare M&A advisory firm.
Facebook
Twitter
LinkedIn
Pinterest